Jim Cramer says these 14 stocks are ‘about to pop’

Jim Cramer says these 14 stocks are ‘about to pop’


CNBC’s Jim Cramer on Wednesday offered investors a list of stocks that he believes could bounce soon.

“The S&P [500]’s down almost 25% for the year, and we’ve gone eleven months since the bear market began. The average bear market only lasts for about 13 months. So maybe we have an expiration date coming up and soon, some of these are going to pop,” he said.

To come up with the companies, he reviewed the S&P 500’s new 52-week low list. Here are his picks:

  1. KeyCorp
  2. Bank of America
  3. JPMorgan Chase
  4. Accenture
  5. ServiceNow
  6. Domino’s Pizza
  7. Yum! Brands
  8. Generac
  9. Stanley Black & Decker
  10. S&P Global
  11. American Tower
  12. Crown Castle
  13. SBA Communications
  14. Mid-America Apartment Communities

Markets have declined considerably this year due to Russia’s invasion of Ukraine, soaring inflation, the Fed’s rate hikes and recession worries.

Cramer said that despite the market’s downturn, PepsiCo‘s revenue and earnings beat for its latest quarter reported Wednesday proves that beaten-down stocks of exceptional companies can bounce. 

Shares of PepsiCo gained 4% on Wednesday.

“I’m just trying to give you a more constructive perspective based on the prism of PepsiCo, a pathetic also-ran that suddenly turned into a big winner, and I think PepsiCo, by the way, is just getting started,” he said.

Jim Cramer’s Guide to Investing

Click here to download Jim Cramer’s Guide to Investing at no cost to help you build long-term wealth and invest smarter.



Source

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
Business

FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi

Signage outside Johnson & Johnson offices in Irvine, California, US, on Friday, Oct. 10, 2025. Kyle Grillot | Bloomberg | Getty Images Johnson & Johnson on Wednesday said the U.S. Food and Drug Administration approved its once-daily psoriasis pill, the first oral option to rival best-selling shots. The FDA approved the pill, Icotyde, to treat […]

Read More
Macy’s store revamp shows progress, but company expects sales to fall this year
Business

Macy’s store revamp shows progress, but company expects sales to fall this year

Macy’s on Wednesday beat Wall Street’s quarterly sales and profit expectations as its namesake brand showed signs of progress, yet still gave a cautious outlook for the year ahead. For the fiscal year, the company – which includes its namesake chain, higher-end department store Bloomingdale’s and beauty retailer Bluemercury – said it expects sales of […]

Read More
Disney embarks on new chapter as Josh D’Amaro takes over as CEO
Business

Disney embarks on new chapter as Josh D’Amaro takes over as CEO

Larissa Manoela and Josh D’Amaro, Chairperson of Walt Disney Parks and Resorts, wave to the audience after Panel Disney Experiences during Day 2 of the D23 Brazil: A Disney Experience at Transamerica Expo Center on November 09, 2024 in Sao Paulo, Brazil. Ricardo Moreira | Getty Images Disney is turning the page on a new […]

Read More